NCT Number: NCT00354692
Effect of Two Iron Preparations on Protein in the Urine
This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Glendale, California, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Moderate to severe anemia
- Iron deficiency
- Moderate to severe chronic kidney disease
- Age ≥ 18 or greater and able to give informed consent
Exclusion criteria
- Receiving dialysis
- Known sensitivity to Sodium Ferric Gluconate Complex in Sucrose Injection, Iron sucrose USP, or any of their components
- Clinically unstable
- Indication of iron sufficiency
Treatment and study plan
Primary outcomes
-
Change in urine protein
Time frame: 180 minutes
Secondary outcomes
-
Change in various urine chemicals
Time frame: 180 minutes
Sponsors and collaborators
Lead sponsor
Watson Pharmaceuticals
Industry
Registry information
Official study title
A Randomized Cross-over Pilot Study of the Effect of Sodium Ferric Gluconate Complex vs. Iron Sucrose on Proteinuria in Non-dialysis Chronic Kidney Disease Patients
Important dates
- Study start
- 2006
- Primary completion
- 2006
- First posted
- Jul 20, 2006
- Registry last updated
- Aug 14, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
NCT00224081
Anemia, Anemia, Hypochromic
Bakersfield, California, United States
View Trial DetailsEffect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
NCT00224042
Anemia, Anemia, Hypochromic
Birmingham, Alabama, United States
View Trial DetailsEffect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
NCT00224055
Anemia, Anemia, Hypochromic
Tucson, Arizona, United States
View Trial DetailsComparison Between Effects of Two Iron Preparations on Protein in the Urine
NCT00534144
Anemia, Anemia, Hypochromic
Phoenix, Arizona, United States
View Trial Details